Anzeige
Mehr »
Samstag, 20.12.2025 - Börsentäglich über 12.000 News
+15% an einem Tag - und dieser Ausbruch hat gerade erst begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoB. Riley Maintains A Neutral Rating On ChargePoint Holdings, Inc. (CHPT)
DoCantor Fitzgerald Bullish On Tesla, Inc. (TSLA)
Do10 Buzzing AI Stocks on Wall Street
DoJim Cramer Recently Discussed These 19 Stocks
DoJim Cramer Was Asked About These 11 Stocks
DoJim Cramer Talked About These 8 Stocks Recently
DoDividend Plans Add a New Angle to Melco Resorts & Entertainment Limited (MLCO)'s Story
DoWhy Recursion Pharmaceuticals, Inc. (RXRX)'s Upside Case Hasn't Fully Convinced Yet
DoWhy Analysts Remain Bullish on CCC Intelligent Solutions Holdings Inc. (CCC)
DoPeloton Interactive, Inc. (PTON)'s Upside Looks Big, But Conviction Remains Split
DoVinFast Auto Ltd. (VFS) Scales Up Indonesia Expansion After Plant Launch
DoTelix Pharmaceuticals Limited (TLX)'s Commercial Progress Meets a Cautious Outlook
DoHere's Why Analysts Are Positive on Aurora Innovation, Inc. (AUR)
DoEvercore Sticks With Bullish Call on Fermi Inc. (FRMI)
Do10 Big Names Investors Are Dumping
MiHSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress
MiAnalysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns Bullish
MiUBS Reiterates Neutral on Novo Nordisk A/S (NVO) Despite Wegovy Dose Progress
MiTruist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure
MiMerck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review
MiBofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight
MiSanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades
MiGuggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review
MiPfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress
MiXBP Global (XBP) Scores Major Inroad Into European Market